IL6 and mastitis: These effects include the attenuation of pro-inflammatory factors like TNF-α, IL-1β, and IL-6 in mastitis-modeled mice by suppressing the toll-like receptor 2 (TLR2), nuclear factor kappa B (NF-κB), and MAPK pathways [47].